Wire · opportunities
Lumos Diagnostics expands FebriDx rollout to 215 US sites
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 15 September 2026 · Fusion42 review
Lumos Diagnostics has expanded its rollout of the FebriDx rapid diagnostic test to 215 urgent care sites across 26 US states, targeting top urgent care groups for broader adoption. The diagnostic helps distinguish bacterial from viral respiratory infections, aiding treatment decisions and antibiotic stewardship.
This Wire brief sits within Fusion42's coverage of Medtech.
◆ ◆ The Wire takeaway
You can now pitch urgent care clinics with evidence from Lumos expanding its rapid respiratory test. Adoption by large US health systems validates the demand for better antibiotic use tools at point of care.
◆ Coverage
1 source · 15 Sep 2026
◆ Related on Wire
◆ Topics